147 related articles for article (PubMed ID: 21167177)
1. Structural insights into the autoinhibition and posttranslational activation of histone methyltransferase SmyD3.
Sirinupong N; Brunzelle J; Doko E; Yang Z
J Mol Biol; 2011 Feb; 406(1):149-59. PubMed ID: 21167177
[TBL] [Abstract][Full Text] [Related]
2. Smyd3 open & closed lock mechanism for substrate recruitment: The hinge motion of C-terminal domain inferred from μ-second molecular dynamics simulations.
Chandramouli B; Silvestri V; Scarno M; Ottini L; Chillemi G
Biochim Biophys Acta; 2016 Jul; 1860(7):1466-74. PubMed ID: 27085704
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain.
Jiang Y; Sirinupong N; Brunzelle J; Yang Z
PLoS One; 2011; 6(6):e21640. PubMed ID: 21738746
[TBL] [Abstract][Full Text] [Related]
4. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
Xu S; Zhong C; Zhang T; Ding J
J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
[TBL] [Abstract][Full Text] [Related]
5. Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.
Silva FP; Hamamoto R; Kunizaki M; Tsuge M; Nakamura Y; Furukawa Y
Oncogene; 2008 Apr; 27(19):2686-92. PubMed ID: 17998933
[TBL] [Abstract][Full Text] [Related]
6. Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3.
Chandramouli B; Chillemi G
J Chem Inf Model; 2016 Dec; 56(12):2467-2475. PubMed ID: 27959541
[TBL] [Abstract][Full Text] [Related]
7. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of cardiac-specific histone methyltransferase SmyD1 reveals unusual active site architecture.
Sirinupong N; Brunzelle J; Ye J; Pirzada A; Nico L; Yang Z
J Biol Chem; 2010 Dec; 285(52):40635-44. PubMed ID: 20943667
[TBL] [Abstract][Full Text] [Related]
9. Domain motions and the open-to-closed conformational transition of an enzyme: a normal mode analysis of S-adenosyl-L-homocysteine hydrolase.
Wang M; Borchardt RT; Schowen RL; Kuczera K
Biochemistry; 2005 May; 44(19):7228-39. PubMed ID: 15882061
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
[TBL] [Abstract][Full Text] [Related]
11. Hit identification of SMYD3 enzyme inhibitors using structure-based pharmacophore modeling.
Alnabulsi SM; Al-Shar'i NA
Future Med Chem; 2019 May; 11(10):1107-1117. PubMed ID: 31280673
[No Abstract] [Full Text] [Related]
12. The N-terminus of Drosophila SU(VAR)3-9 mediates dimerization and regulates its methyltransferase activity.
Eskeland R; Czermin B; Boeke J; Bonaldi T; Regula JT; Imhof A
Biochemistry; 2004 Mar; 43(12):3740-9. PubMed ID: 15035645
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the Conformational Change of the Protein Methyltransferase SMYD3: A Molecular Dynamics Simulation Study.
Sun J; Li Z; Yang N
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281237
[TBL] [Abstract][Full Text] [Related]
14. A 1.8 A resolution structure of pig muscle 3-phosphoglycerate kinase with bound MgADP and 3-phosphoglycerate in open conformation: new insight into the role of the nucleotide in domain closure.
Szilágyi AN; Ghosh M; Garman E; Vas M
J Mol Biol; 2001 Feb; 306(3):499-511. PubMed ID: 11178909
[TBL] [Abstract][Full Text] [Related]
15. Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets.
Van Aller GS; Graves AP; Elkins PA; Bonnette WG; McDevitt PJ; Zappacosta F; Annan RS; Dean TW; Su DS; Carpenter CL; Mohammad HP; Kruger RG
Structure; 2016 May; 24(5):774-781. PubMed ID: 27066749
[TBL] [Abstract][Full Text] [Related]
16. SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax.
Yamamoto K; Ishida T; Nakano K; Yamagishi M; Yamochi T; Tanaka Y; Furukawa Y; Nakamura Y; Watanabe T
Cancer Sci; 2011 Jan; 102(1):260-6. PubMed ID: 21054678
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional profiling of the human histone methyltransferase SMYD3.
Foreman KW; Brown M; Park F; Emtage S; Harriss J; Das C; Zhu L; Crew A; Arnold L; Shaaban S; Tucker P
PLoS One; 2011; 6(7):e22290. PubMed ID: 21779408
[TBL] [Abstract][Full Text] [Related]
18. C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis.
Brown MA; Foreman K; Harriss J; Das C; Zhu L; Edwards M; Shaaban S; Tucker H
Oncotarget; 2015 Feb; 6(6):4005-19. PubMed ID: 25738358
[TBL] [Abstract][Full Text] [Related]
19. Differential binding of S-adenosylmethionine S-adenosylhomocysteine and Sinefungin to the adenine-specific DNA methyltransferase M.TaqI.
Schluckebier G; Kozak M; Bleimling N; Weinhold E; Saenger W
J Mol Biol; 1997 Jan; 265(1):56-67. PubMed ID: 8995524
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
